Last edition
News about "Pritelivir for Herpes Simplex Virus"
US FDA Approves Drug to Treat Lesions Due to Herpes Simplex Virus
The US FDA has approved a drug to treat Herpes Simplex Virus (HSV-1 and HSV-2) lesions, which can cause painful blisters and mucocutaneous sores.
Pritelivir For Herpes Simplex Virus | 13/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members